Perspective Therapeutics Inc. CATX
$2.95
▼ -0.67% 24H
About
Perspective Therapeutics Inc. is a biotechnology company focused on the discovery, development, and commercialization of innovative therapeutics and technologies to treat various diseases, primarily within the oncology sector. Its primary function is to advance research that can lead to practical cancer treatment solut…
SectorHealthcare
ExchangeNYSE
IndustryMedical Devices
CountryUnited States
Employees138
TickerCATX
Statistics
Market Cap$336.4M
Revenue (TTM)$0
Net Income-$103.1M
Net Margin—
EPS$-1.40
P/E-2.12
P/S544.40
P/B0.97
EV/EBITDA-0.60
ROE-35.3%
Dividend Yield—
Price$2.95
Data: Twelve Data · Revenue = mcap / P/S